Valuation : Supergenics

Market Cap 29.11M 7.2M 6.19M 5.83M 5.32M 9.96M 680M 9.98M 68.85M 26.72M 349M 27.03M 26.44M 1.12B P/E 2024
-9.45x
P/E 2025 -8.61x
Enterprise Value 32.5M 8.04M 6.92M 6.51M 5.94M 11.12M 759M 11.15M 76.88M 29.83M 389M 30.18M 29.52M 1.25B EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 year 0.2
Extreme 0.205
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-04-23
Corporate Secretary - 2022-06-01
Director TitleAgeSince
Director/Board Member 48 2019-04-23
Director/Board Member 60 2019-04-23
Director/Board Member 46 2022-01-27
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%-16.67%+8.70% 7.2M
-2.54%-2.84%-1.77%+14.72% 48.93B
-0.40%+1.03%+418.57%+523.39% 45.01B
-1.42%+2.30%+42.67%+21.22% 44.07B
-1.22%-2.31%+4.82%+74.90% 40.73B
+0.53%-1.36%+16.87%+47.12% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+21.42%+123.04% 16.5B
-1.01%+0.50%+13.91%+31.45% 14.67B
-1.65%-1.03%+75.93%+41.22% 13.77B
Average +1.37%+0.48%+63.97%+98.42% 27.5B
Weighted average by Cap. -1.03%+0.11%+89.42%+127.93%

Financials

2024 2025
Net sales 5.32M 1.32M 1.13M 1.07M 973K 1.82M 124M 1.83M 12.59M 4.88M 63.74M 4.94M 4.83M 205M 5.63M 1.39M 1.2M 1.13M 1.03M 1.92M 131M 1.93M 13.31M 5.16M 67.38M 5.22M 5.11M 217M
Net income -7.28M -1.8M -1.55M -1.46M -1.33M -2.49M -170M -2.5M -17.22M -6.68M -87.21M -6.76M -6.61M -281M -3.37M -832K -716K -674K -615K -1.15M -78.57M -1.15M -7.96M -3.09M -40.31M -3.12M -3.06M -130M
Net Debt 4.48M 1.11M 953K 896K 819K 1.53M 105M 1.54M 10.59M 4.11M 53.62M 4.16M 4.07M 173M 3.39M 839K 722K 679K 621K 1.16M 79.24M 1.16M 8.03M 3.12M 40.65M 3.15M 3.08M 131M
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock